We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-6.45%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$440M
AUM Growth
+$68.3M
Cap. Flow
+$121M
Cap. Flow %
27.55%
Top 10 Hldgs %
7.16%
Holding
1,009
New
355
Increased
190
Reduced
143
Closed
321

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.33M
2
AZN icon
AstraZeneca
AZN
+$3.83M
3
SPB icon
Spectrum Brands
SPB
+$3.54M
4
BNS icon
Scotiabank
BNS
+$3.5M
5
TSN icon
Tyson Foods
TSN
+$3.37M

Top Sells

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$3.48M
2
DOV icon
Dover
DOV
+$2.95M
3
TU icon
Telus
TU
+$2.82M
4
SYK icon
Stryker
SYK
+$2.58M
5
TTWO icon
Take-Two Interactive
TTWO
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 18.71%
2 Technology 17.25%
3 Industrials 13.57%
4 Financials 13.31%
5 Consumer Discretionary 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LFUS icon
451
Littelfuse
LFUS
$11.4B
$328K 0.07%
+1,653
New +$395K
TALO icon
452
Talos Energy
TALO
$2.58B
$327K 0.07%
19,615
-1,385
-7% -$24.8K
MGEE icon
453
MGE Energy Inc
MGEE
$3.06B
$326K 0.07%
+4,965
New +$389K
ETD icon
454
Ethan Allen Interiors
ETD
$583M
$325K 0.07%
+15,377
New +$359K
CNXN icon
455
PC Connection
CNXN
$2.04B
$324K 0.07%
7,196
-6,461
-47% -$305K
F icon
456
Ford
F
$55.4B
$323K 0.07%
28,813
-19,689
-41% -$276K
FATE icon
457
Fate Therapeutics
FATE
$294M
$323K 0.07%
+14,432
New +$417K
CVSA
458
Covista Inc
CVSA
$4.49B
$320K 0.07%
8,778
-4,129
-32% -$158K
AVT icon
459
Avnet
AVT
$7.87B
$317K 0.07%
8,774
+1,831
+26% +$78.8K
BPOP icon
460
Popular Inc
BPOP
$11.3B
$316K 0.07%
+4,386
New +$341K
EWBC icon
461
East-West Bancorp
EWBC
$18.6B
$314K 0.07%
4,681
+165
+4% +$11.7K
GOGO icon
462
Gogo Inc
GOGO
$377M
$313K 0.07%
+25,840
New +$393K
JBL icon
463
Jabil
JBL
$38.8B
$313K 0.07%
+5,423
New +$316K
AMKR icon
464
Amkor Technology
AMKR
$14.3B
$312K 0.07%
+18,307
New +$352K
EPM icon
465
Evolution Petroleum
EPM
$135M
$312K 0.07%
44,892
-28,690
-39% -$189K
BCE icon
466
BCE
BCE
$21.7B
$311K 0.07%
+7,415
New +$360K
ACM icon
467
Aecom
ACM
$8.19B
$310K 0.07%
+4,538
New +$322K
ALV icon
468
Autoliv
ALV
$8.89B
$308K 0.07%
+4,625
New +$359K
PAHC icon
469
Phibro Animal Health
PAHC
$1.38B
$308K 0.07%
23,177
-843
-4% -$14.6K
PLD icon
470
Prologis
PLD
$134B
$307K 0.07%
3,022
-8
-0.3% -$992
AM icon
471
Antero Midstream
AM
$10.5B
$306K 0.07%
33,306
-11,542
-26% -$114K
EGP icon
472
EastGroup Properties
EGP
$11B
$306K 0.07%
2,121
-519
-20% -$84.7K
EXP icon
473
Eagle Materials
EXP
$6.41B
$306K 0.07%
+2,852
New +$341K
GNK icon
474
Genco Shipping & Trading
GNK
$1.13B
$306K 0.07%
24,385
-7,303
-23% -$116K
MT icon
475
ArcelorMittal
MT
$55.2B
$303K 0.07%
+15,208
New +$348K
17 18
19
20 21

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Campbell & Co Investment Adviser's Q3 2022 Portfolio in Review

As of Q3 2022, Campbell & Co Investment Adviser held 1,009 positions worth $440M, up 18% from $372M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Campbell & Co Investment Adviser deployed $121M of net new capital in Q3 2022, opening 355 new positions and adding to 190 existing holdings. Its largest new stake was GSK: 193,518 shares worth $5.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dover, an estimated $2.95M trimmed.

  • Campbell & Co Investment Adviser's largest Q3 2022 buy was GSK: 193,518 shares worth $5.7M.
  • Campbell & Co Investment Adviser added most to Scotiabank in Q3 2022, an estimated $3.5M increase.
  • Campbell & Co Investment Adviser's biggest Q3 2022 reduction was Dover, cutting an estimated $2.95M.
  • Campbell & Co Investment Adviser fully exited Virtu Financial in Q3 2022, selling an estimated $3.48M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 7.2% of its $440M portfolio in Q3 2022.
  • Campbell & Co Investment Adviser opened 355 new positions and closed 321 in Q3 2022.
  • Campbell & Co Investment Adviser's portfolio value rose 18% quarter-over-quarter to $440M.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2022, filed 14 Nov 2022.